The effect of staff training on agitation and use of restraint in nursing home residents with dementia: a single-blind, randomized controlled trial

The Journal of Clinical Psychiatry
I TestadD Aarsland

Abstract

Agitation is common in dementia and is associated with use of restraints and use of psychotropic drugs. The aim of this study was to determine whether an education and supervision intervention could reduce agitation and the use of restraints and antipsychotic drugs in nursing homes. Four Norwegian nursing homes were randomly allocated to receive either treatment as usual or an intervention consisting of a 2-day educational seminar and monthly group guidance for 6 months. One hundred forty-five residents with dementia (based on medical records and corroborated with a Functional Assessment Staging score >or= 4) completed baseline and 6-month intervention assessments and were included in the analyses. The co-primary outcome measures were the proportion of residents subject to interactional restraint and the severity of agitation using the Cohen-Mansfield Agitation Inventory (CMAI). Patients were assessed at baseline, immediately after completion of the intervention at 6 months, and 12 months after baseline. Comparison of change in the 2 groups was made using repeated-measures analysis of variance (CMAI) and Mann-Whitney test (restraints). The study was conducted from 2003 to 2004. The proportion of residents starting new restraint...Continue Reading

Citations

Apr 20, 2011·Current Oncology Reports·Anita-Luise Küpper, Julian C Hughes
Oct 19, 2013·Current Treatment Options in Neurology·Jiska Cohen-Mansfield
Sep 4, 2010·International Psychogeriatrics·Erik J A ScherderDick F Swaab
Aug 3, 2010·British Medical Bulletin·Elizabeth L Sampson
Sep 15, 2010·Current Opinion in Psychiatry·David K Conn, Dallas P Seitz
Jul 26, 2014·The British Journal of Psychiatry : the Journal of Mental Science·Elizabeth L SampsonLouise Jones
Jun 13, 2013·Revista española de geriatría y gerontología·Emilio Fariña-LópezManuel Gandoy Crego
Nov 19, 2011·Journal of the American Geriatrics Society·Math J M GulpersJan P H Hamers
Apr 17, 2015·Health and Quality of Life Outcomes·Stefanie AuerKatharina Luttenberger
Apr 24, 2013·Journal of the American Medical Directors Association·Michel H C BleijlevensJan P H Hamers
Feb 17, 2017·Acta Clinica Belgica·Majda AzermaiMirko Petrovic
Feb 15, 2014·American Journal of Alzheimer's Disease and Other Dementias·Jiska Cohen-MansfieldRinat Cohen
Feb 28, 2013·Nursing Ethics·Elisabeth GjerbergReidar Pedersen
Feb 18, 2011·The Cochrane Database of Systematic Reviews·Ralph MöhlerGabriele Meyer
Jul 19, 2018·The Cochrane Database of Systematic Reviews·Sally SpencerIan C Smith
Aug 16, 2017·The Kaohsiung Journal of Medical Sciences·Shao-Huan LanLong-Yau Lin
Mar 18, 2016·The Medical Journal of Australia·Kate LaverMark W Yates
Aug 28, 2020·The British Journal of Psychiatry : the Journal of Mental Science·Corrado BarbuiGraham Thornicroft
Jul 25, 2020·Neurological Research·Gary L Hoover, Victoria C Whitehair
Dec 13, 2019·Scandinavian Journal of Caring Sciences·Bilge Kalanlar, Nilgün Kuru Alici
Apr 4, 2021·International Journal of Environmental Research and Public Health·Lauren M RobinsTerry P Haines
Jun 3, 2021·International Journal of Older People Nursing·Paula PiirainenSatu Elo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here